BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1946090)

  • 1. [Allogeneic lymphocytic cytotoxicity].
    Orlewska E; Olszewski WL
    Postepy Hig Med Dosw; 1991; 45(3-4):173-85. PubMed ID: 1946090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rapid rejection of allogeneic lymphocytes by a non-adaptive, cell-mediated mechanism (NK activity).
    Rolstad B; Fossum S; Bazin H; Kimber I; Marshall J; Sparshott SM; Ford WL
    Immunology; 1985 Jan; 54(1):127-38. PubMed ID: 3972430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of natural killer cells and macrophages on the course of acute graft rejection following allogeneic heart transplantation in the rat.
    Dresske B; Zhu X; Peters J; Brötzmann K; Fändrich F
    Transplant Proc; 1996 Dec; 28(6):3259-60. PubMed ID: 8962264
    [No Abstract]   [Full Text] [Related]  

  • 4. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC.
    Rolstad B; Fossum S
    Immunology; 1987 Feb; 60(2):151-7. PubMed ID: 2434415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibody-dependent cell cytotoxicity and spontaneous cytotoxicity of peripheral blood lymphocytes of organ recipients and cells infiltrating the kidney allogeneic transplant].
    Drannik GN; Baran EIa; Seniuk OF; Driianskaia VE
    Fiziol Zh (1978); 1989; 35(5):68-72. PubMed ID: 2591583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the major histocompatibility complex class I regions in rat natural killer cell allograft responses in vivo and in vitro.
    Rolstad B
    Chem Immunol; 1996; 64():59-76. PubMed ID: 8942072
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes (LGL).
    Rolstad B; Herberman RB; Reynolds CW
    J Immunol; 1986 Apr; 136(8):2800-8. PubMed ID: 3485674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas-mediated cytotoxicity by gammadelta T cells during acute rejection in xenotransplantation of spheroidal aggregate-cultured hepatocytes.
    Ota K; Yagi T; Iwagaki H; Morimoto Y; Sadamori H; Inagaki M; Urushihara N; Matsuno T; Saito S; Tanaka N
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):43-54. PubMed ID: 10850368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK activity during graft-versus-host disease and graft rejection in rats following intestinal semiallogenic and allogenic transplantation with or without mesenteric lymphadenectomy.
    Frezza EE; Gerunda GE; Fassina A; DeFranchis R; Biffi R; Gurakar A; Fagiuoli S; Faccioli AM; Van Thiel DH
    Transplantation; 1994 Sep; 58(6):698-701. PubMed ID: 7940689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic heart transplantation activates alloreactive NK cells.
    Petersson E; Ostraat O; Ekberg H; Hansson J; Simanaitis M; Brodin T; Dohlsten M; Hedlund G
    Cell Immunol; 1997 Jan; 175(1):25-32. PubMed ID: 9015185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rapid elimination of allogeneic lymphocytes: relationship to established mechanisms of immunity and to lymphocyte traffic.
    Rolstad B; Ford WL
    Immunol Rev; 1983; 73():87-113. PubMed ID: 6350161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I.
    Koike J; Wakao H; Ishizuka Y; Sato TA; Hamaoki M; Seino K; Koseki H; Nakayama T; Taniguchi M
    J Exp Med; 2004 Jan; 199(1):137-44. PubMed ID: 14707119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
    Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
    J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E; Yamamoto H; Kaplan J
    J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The F1 hybrid effect in allogeneic lymphocyte cytotoxicity. Points of similarity between hybrid resistance and ALC.
    Heslop BF; McNeilage LJ
    Transplantation; 1989 Oct; 48(4):634-9. PubMed ID: 2799917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.